₹218.9 -3.4 -1.5%
Last Trade - 09/04/21
| Market Cap | £2.06bn |
| Enterprise Value | £2.20bn |
| Revenue | £103.4m |
| Position in Universe | 185th / 3106 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 0.000 | 16,910 | 10,590 | 36,980 | 46,265 | -37.4% | ||
| +187.3 | +217.1 | |||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Max Healthcare Institute Limited is an India-based healthcare company. The Company provides healthcare services across secondary and tertiary care specialties with focus on oncology, neurosciences, cardiac sciences, orthopedics, renal sciences, liver and biliary sciences and minimal access metabolic and bariatric surgery (MAMBS). Max@Home is a platform that provides health and wellness services at home and MaxLab offers pathology services to patients outside of its hospitals through a variety of channels, including third party hospital laboratory management.
| Last Annual | March 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | June 18, 2001 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | |
| Exchange | National Stock Exchange of India |
| Shares in Issue | 965,945,006 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | Max House 1 Dr Jha Margokhla, GURGAON, 122002, India |
| Web | https://www.maxhealthcare.in/ |
| Phone | +91 11 26515050 |
| Contact | () |
| Auditors | S.R. Batliboi & Co. LLP |
As of 09/04/21, shares in Max Healthcare Institute are trading at ₹218.9, giving the company a market capitalisation of £2.06bn. This share price information is delayed by 15 minutes.
Shares in Max Healthcare Institute are currently trading at ₹218.9 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Max Healthcare Institute price has moved by % over the past year.
There are no analysts currently covering Max Healthcare Institute.
Max Healthcare Institute is scheduled to issue upcoming financial results on the following dates:
Max Healthcare Institute does not currently pay a dividend.
Max Healthcare Institute does not currently pay a dividend.
Max Healthcare Institute does not currently pay a dividend.
To buy shares in Max Healthcare Institute you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Max Healthcare Institute are currently trading at ₹218.9, giving the company a market capitalisation of £2.06bn.
Here are the trading details for Max Healthcare Institute:
Based on an overall assessment of its quality, value and momentum, Max Healthcare Institute is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Max Healthcare Institute are currently priced at ₹218.9. At that level they are trading at 4.84% discount to the analyst consensus target price of 0.00.
Analysts covering Max Healthcare Institute currently have a consensus Earnings Per Share (EPS) forecast of 1.861 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Max Healthcare Institute. Over the past six months, the relative strength of its shares against the market has been 56.97%. At the current price of ₹218.9, shares in Max Healthcare Institute are trading at 48.39% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Max Healthcare Institute PE ratio based on its reported earnings over the past 12 months is 0.338k. The shares are currently trading at ₹218.9.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We were unable to find the directors for Max Healthcare Institute.
Here are the top five shareholders of Max Healthcare Institute based on the size of their shareholding:
